ResearcherChinese Academy of Medical Sciences & Peking Union Medical CollegeActive in the last 2 years
Junchao Guo
Matched on ORCID iD 0000-0002-7287-9064; OpenAlex author ID A5101711931. Sources: OpenAlex.
Their work
- Papers
- 10 (first author 0, last author 3)
- Trials
- 0
- Grants
- 0
- Labs led
- 1
- Collaborators
- 32
2015: 1 paper · 2016: 1 paper · 2017: none · 2018: none · 2019: none · 2020: 3 papers · 2021: 1 paper · 2022: none · 2023: none · 2024: 1 paper · 2025: 2 papers · 2026: 1 paper
Papers 10
- Identifying a better-prognosis pancreatic cancer from its benign inflammatory mimic: a machine learning approach with contrast-enhanced ultrasound for early in… Co-author DOI 10.1007/s00261-026-05423-2↗
- Development and validation of a nomogram model based on ultrasound and contrast-enhanced ultrasound features for differentiating mass-forming pancreatitis and … Co-author DOI 10.1007/s00261-025-05035-2↗
- Serum microRNA-24-based nomogram predicts prognosis for patients with resected pancreatic cancer. Co-author DOI 10.1038/s41598-024-82369-9↗
- Construction and Validation of a Novel T/NK-Cell Prognostic Signature for Pancreatic Cancer Based on Single-Cell RNA Sequencing. Last author DOI 10.1080/07357907.2024.2424328↗
- MicroRNA-34a Alleviates Gemcitabine Resistance in Pancreatic Cancer by Repression of Cancer Stem Cell Renewal. Co-author DOI 10.1097/mpa.0000000000001920↗
- Ubiquitin-specific protease 4 predicts an unfavorable prognosis and promotes malignant behaviors in vitro in pancreatic cancer. Last author DOI 10.1016/j.yexcr.2020.112317↗
- Research progress on long non-coding RNAs and their roles as potential biomarkers for diagnosis and prognosis in pancreatic cancer. Co-author DOI 10.1186/s12935-020-01550-y↗
- Stroma-Targeting Therapy in Pancreatic Cancer: One Coin With Two Sides? Last author DOI 10.3389/fonc.2020.576399↗
- CXCL12-CXCR7 axis contributes to the invasive phenotype of pancreatic cancer. Co-author DOI 10.18632/oncotarget.11330↗
- Expression of c-fos was associated with clinicopathologic characteristics and prognosis in pancreatic cancer. Co-author DOI 10.1371/journal.pone.0120332↗
Closest collaborators
The 25 strongest of 32 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Menghua Dai · 2 shared papers, 2025–2026 · strength 0.48
- Paper Identifying a better-prognosis pancreatic cancer from its benign inflammatory mimic: a machine learning approach with c… DOI 10.1007/s00261-026-05423-2↗
- Paper Development and validation of a nomogram model based on ultrasound and contrast-enhanced ultrasound features for differ… DOI 10.1007/s00261-025-05035-2↗
- Weibin Wang · 2 shared papers, 2025–2026 · strength 0.48
- Paper Identifying a better-prognosis pancreatic cancer from its benign inflammatory mimic: a machine learning approach with c… DOI 10.1007/s00261-026-05423-2↗
- Paper Development and validation of a nomogram model based on ultrasound and contrast-enhanced ultrasound features for differ… DOI 10.1007/s00261-025-05035-2↗
- Gary Guishan Xiao · 3 shared papers, 2020–2025 · strength 0.48
- Paper Serum microRNA-24-based nomogram predicts prognosis for patients with resected pancreatic cancer. DOI 10.1038/s41598-024-82369-9↗
- Paper Research progress on long non-coding RNAs and their roles as potential biomarkers for diagnosis and prognosis in pancre… DOI 10.1186/s12935-020-01550-y↗
- Paper MicroRNA-34a Alleviates Gemcitabine Resistance in Pancreatic Cancer by Repression of Cancer Stem Cell Renewal. DOI 10.1097/mpa.0000000000001920↗
- Li Zhou · 4 shared papers, 2016–2020 · strength 0.43
- Paper Research progress on long non-coding RNAs and their roles as potential biomarkers for diagnosis and prognosis in pancre… DOI 10.1186/s12935-020-01550-y↗
- Paper Stroma-Targeting Therapy in Pancreatic Cancer: One Coin With Two Sides? DOI 10.3389/fonc.2020.576399↗
- Paper Ubiquitin-specific protease 4 predicts an unfavorable prognosis and promotes malignant behaviors in vitro in pancreatic… DOI 10.1016/j.yexcr.2020.112317↗
- Bolun Jiang · 3 shared papers, 2020 · strength 0.37
- Paper Research progress on long non-coding RNAs and their roles as potential biomarkers for diagnosis and prognosis in pancre… DOI 10.1186/s12935-020-01550-y↗
- Paper Stroma-Targeting Therapy in Pancreatic Cancer: One Coin With Two Sides? DOI 10.3389/fonc.2020.576399↗
- Paper Ubiquitin-specific protease 4 predicts an unfavorable prognosis and promotes malignant behaviors in vitro in pancreatic… DOI 10.1016/j.yexcr.2020.112317↗
- Jun Lü · 3 shared papers, 2020 · strength 0.37
- Paper Research progress on long non-coding RNAs and their roles as potential biomarkers for diagnosis and prognosis in pancre… DOI 10.1186/s12935-020-01550-y↗
- Paper Stroma-Targeting Therapy in Pancreatic Cancer: One Coin With Two Sides? DOI 10.3389/fonc.2020.576399↗
- Paper Ubiquitin-specific protease 4 predicts an unfavorable prognosis and promotes malignant behaviors in vitro in pancreatic… DOI 10.1016/j.yexcr.2020.112317↗
- Jianzhou Liu · 2 shared papers, 2021–2025 · strength 0.35
- Vay Liang W. Go · 2 shared papers, 2021–2025 · strength 0.35
- Yu Wang · 1 shared paper, 2024 · strength 0.28
- Hua Liang · 1 shared paper, 2026 · strength 0.26
- Ke Lv · 1 shared paper, 2026 · strength 0.26
- Zhuhuang Zhou · 1 shared paper, 2026 · strength 0.26
- Yuxin Jiang · 1 shared paper, 2026 · strength 0.26
- Yizhi Wang · 2 shared papers, 2020 · strength 0.24
- Paper Research progress on long non-coding RNAs and their roles as potential biomarkers for diagnosis and prognosis in pancre… DOI 10.1186/s12935-020-01550-y↗
- Paper Ubiquitin-specific protease 4 predicts an unfavorable prognosis and promotes malignant behaviors in vitro in pancreatic… DOI 10.1016/j.yexcr.2020.112317↗
- Lei You · 3 shared papers, 2015–2020 · strength 0.24
- Paper Stroma-Targeting Therapy in Pancreatic Cancer: One Coin With Two Sides? DOI 10.3389/fonc.2020.576399↗
- Paper CXCL12-CXCR7 axis contributes to the invasive phenotype of pancreatic cancer. DOI 10.18632/oncotarget.11330↗
- Paper Expression of c-fos was associated with clinicopathologic characteristics and prognosis in pancreatic cancer. DOI 10.1371/journal.pone.0120332↗
- Qian Zhang · 1 shared paper, 2025 · strength 0.23
- Jing Huang · 1 shared paper, 2025 · strength 0.23
- Yongwei Sun · 1 shared paper, 2025 · strength 0.23
- Minwei Yang · 1 shared paper, 2025 · strength 0.23
- Yuxin Jiang · 1 shared paper, 2025 · strength 0.22
- Qiang Xu · 1 shared paper, 2025 · strength 0.22
- Hua Liang · 1 shared paper, 2025 · strength 0.22
- Ke Lv · 1 shared paper, 2025 · strength 0.22
- Zhiyong Liang · 2 shared papers, 2016–2020 · strength 0.18
- Yizhi Wang · 1 shared paper, 2020 · strength 0.13
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.